| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.22B | $1.25B | $1.57B |
| YoY Revenue Growth % | +77.0% | -19.9% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $645.9M | -$168.6M | $226.6M |
| Operating Margin % | 29.1% | -13.4% | 14.5% |
| Net Income (GAAP) | $395.6M | -$229.7M | $211.1M |
| EBITDA (Normalized) | $1.73B | $709.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $899.6M | $620.3M | $1.02B |
| Capital Expenditures (CapEx) | $1.35B | $1.10B | — |
| Free Cash Flow (FCF) | -$449.7M | -$477.1M | $1.02B |
| FCF Margin % | -20.3% | -38.0% | 65.0% |
| Return on Invested Capital (ROIC %) | 9.4% | -2.6% | — |
| Cash & Short-Term Equivalents | $23.9M | $6.8M | — |
| Total Debt (Short + Long Term) | $2.81B | $2.95B | — |
| Total Stockholders' Equity | $2.65B | $2.24B | — |